Company
Medtronic
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
607
510(k), De Novo and PMA
Device trials
700
As lead sponsor, any status
Adverse event reports
389,763
Received Nov 1, 2025 to Nov 20, 2026
Recall records
2,615
One per recalled product
Medtronic is on our public-company list (ticker MDT). Names searched as well: Covidien, Medtronic Vascular, Medtronic Sofamor Danek, Medtronic MiniMed. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
MDT
NYSE · Medtronic plc
Public float
$120.1B
Value of shares held by non-insiders on Oct 24, 2025
Revenue
$36.4B
Fiscal year ending Apr 24, 2026
Net income
$4.80B
Fiscal year ending Apr 24, 2026
R&D spending
$2.87B
Fiscal year ending Apr 24, 2026
Cash
$1.69B
As of Jul 31, 2026
Long-term debt
$25.6B
As of Jul 31, 2026
Shares outstanding
1279.1M
As of Aug 28, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2026 | $538M | $516M | $1.75B | – |
| 2025 | – | $508M | $3.21B | – |
| 2024 | – | $284M | – | – |
| 2023 | – | – | $5.41B | – |
| 2021 | – | – | $7.17B | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
The 8 newest of 607 since 2015.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
606 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT01526811 · 180 participants · Start Mar 2012 · Primary completion Dec 21, 2018
Device: Endurant Stent graft · For: Aneurysm; Aortic Aneurysm; Aortic Aneurysm, Abdominal and 3 more
Sites: Avignon, France; Besançon, France; Challes-les-Eaux, France · 20 sites in all
699 more trials with a free account
Reports received
389,763
Received Nov 1, 2025 to Nov 20, 2026. Includes 62 of another or unstated type.
Malfunction reports
320,330
82% of reports
Injury reports
67,518
17% of reports
Death reports
1,853
0.5% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 16,095 | 3,656 | 134 | 2 |
| Jan 24 | 21,558 | 4,620 | 200 | 3 |
| Feb 24 | 20,828 | 3,685 | 185 | 3 |
| Mar 24 | 18,269 | 3,900 | 218 | 0 |
| Apr 24 | 15,943 | 3,608 | 212 | 0 |
| May 24 | 21,866 | 3,723 | 153 | 4 |
| Jun 24 | 15,813 | 3,558 | 110 | 1 |
| Jul 24 | 21,356 | 5,042 | 177 | 2 |
| Aug 24 | 19,796 | 3,637 | 137 | 1 |
| Sep 24 | 20,393 | 3,550 | 99 | 3 |
| Oct 24 | 18,825 | 4,017 | 181 | 5 |
| Nov 24 | 18,345 | 3,769 | 116 | 6 |
| Dec 24 | 23,247 | 3,731 | 150 | 2 |
| Jan 25 | 23,663 | 4,066 | 159 | 2 |
| Feb 25 | 15,707 | 3,174 | 106 | 4 |
| Mar 25 | 19,244 | 3,625 | 168 | 3 |
| Apr 25 | 22,771 | 4,126 | 254 | 1 |
| May 25 | 22,317 | 4,108 | 143 | 0 |
| Jun 25 | 20,502 | 4,171 | 145 | 2 |
| Jul 25 | 27,515 | 5,836 | 223 | 0 |
| Aug 25 | 24,583 | 5,348 | 150 | 1 |
| Sep 25 | 34,159 | 6,397 | 159 | 3 |
| Oct 25 | 28,580 | 6,142 | 206 | 0 |
| Nov 25 | 21,766 | 4,968 | 127 | 0 |
| Dec 25 | 27,704 | 5,058 | 183 | 0 |
| Jan 26 | 22,597 | 5,664 | 182 | 0 |
| Feb 26 | 26,816 | 5,790 | 168 | 0 |
| Mar 26 | 30,669 | 5,633 | 167 | 0 |
| Apr 26 | 31,790 | 6,972 | 183 | 0 |
| May 26 | 25,540 | 5,200 | 166 | 0 |
| Jun 26 | 28,255 | 5,437 | 151 | 1 |
| Jul 26 | 30,137 | 5,632 | 160 | 10 |
| Aug 26 | 21,815 | 5,625 | 88 | 47 |
| Sep 26 | 25,233 | 5,616 | 121 | 3 |
| Oct 26 | 28,008 | 5,923 | 157 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- CareLink SmartSync Programmer, Model 24970A, Pulse generator, permanent, implantableOpen, Classified
Z-0302-2027 · Started Sep 24, 2026 · Posted by FDA Oct 27, 2026
Reason given: Software problem has the potential for an inaccurate displayed longevity estimate.
Cause as FDA categorized it: Software design · Device type: Pulse Generator, Permanent, Implantable (NVZ)
2,614 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.